Buyer Name: NHS England
Buyer Address: Wellington House, 133-135 Waterloo Rd, London, UKI45, SE1 8UG, United Kingdom
Contact Email: david.ford1@nhs.net
Buyer Name: NHS England
Buyer Address: Wellington House, 133-135 Waterloo Rd, London, UKI45, SE1 8UG, United Kingdom
Contact Email: david.ford1@nhs.net
NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. Offer reference number: CM/PHG/24/5716 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Periods of call-offs under the framework agreement: CM/PHG/24/5716/01– NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028
External Link: https://www.find-tender.service.gov.uk/Notice/010573-2026
Link Description: Tender notice on Find a Tender
Lot Title: Lenalidomide
Lot Description: Lenalidomide CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028
Lot 1 Status: active
Lot 1 Has Options: Yes
Lot 1 Options: option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Lot 1 Value: GBP 1.00
Lot 1 Value (Gross): GBP 1.00
Lot 1 Contract Start: 2026-06-01T00:00:00+01:00
Lot 1 Contract End: 2028-05-31T23:59:59+01:00
Lot 1 SME Suitable: Yes
Lot 1 Award Criterion (price): Price
Lot Title: Pomalidomide
Lot Description: Pomalidomide CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028
Lot 2 Status: active
Lot 2 Has Options: Yes
Lot 2 Options: option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Lot 2 Value: GBP 1.00
Lot 2 Value (Gross): GBP 1.00
Lot 2 Contract Start: 2026-06-01T00:00:00+01:00
Lot 2 Contract End: 2028-05-31T23:59:59+01:00
Lot 2 SME Suitable: Yes
Lot 2 Award Criterion (price): Price
Lot Title: Thalidomide
Lot Description: Thalidomide CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028
Lot 3 Status: active
Lot 3 Has Options: Yes
Lot 3 Options: option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Lot 3 Value: GBP 1.00
Lot 3 Value (Gross): GBP 1.00
Lot 3 Contract Start: 2026-06-01T00:00:00+01:00
Lot 3 Contract End: 2028-05-31T23:59:59+01:00
Lot 3 SME Suitable: Yes
Lot 3 Award Criterion (price): Price
Document Description: Tender notice on Find a Tender
{
"buyer": {
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England"
},
"date": "2026-02-05T15:03:18Z",
"id": "010573-2026",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-051c39",
"parties": [
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "SE1 8UG",
"region": "UKI45",
"streetAddress": "Wellington House, 133-135 Waterloo Rd"
},
"contactPoint": {
"email": "david.ford1@nhs.net"
},
"details": {
"classifications": [
{
"description": "Public authority - central government",
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE"
}
],
"url": "https://www.england.nhs.uk/"
},
"id": "GB-PPON-PDPT-3135-BWWY",
"identifier": {
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
},
"name": "NHS England",
"roles": [
"buyer"
]
}
],
"tag": [
"tender"
],
"tender": {
"aboveThreshold": true,
"awardPeriod": {
"endDate": "2026-03-16T23:59:59Z"
},
"coveredBy": [
"GPA"
],
"description": "NHS National Framework for Lenalidomide, Pomalidomide \u0026 Thalidomide.\nOffer reference number: CM/PHG/24/5716\nPeriod of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.\nPeriods of call-offs under the framework agreement:\nCM/PHG/24/5716/01\u2013 NHS National Framework for Lenalidomide, Pomalidomide \u0026 Thalidomide.\nCESW: (Midlands and Southwest): 1st June 2026 \u2013 31st May 2028\nNWLN: (Northwest and London North): 1st June 2026 \u2013 31st May 2028\nLSNE: (London South and Northeast): 1st June 2026 \u2013 31st May 2028",
"documents": [
{
"documentType": "biddingDocuments",
"format": "application/x-zip-compressed",
"id": "A-11587",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-11587"
},
{
"documentType": "conflictOfInterest",
"id": "conflictOfInterest"
},
{
"datePublished": "2026-02-05T15:03:18Z",
"description": "Tender notice on Find a Tender",
"documentType": "tenderNotice",
"format": "text/html",
"id": "010573-2026",
"noticeType": "UK4",
"url": "https://www.find-tender.service.gov.uk/Notice/010573-2026"
}
],
"enquiryPeriod": {
"endDate": "2026-03-02T17:00:00Z"
},
"id": "CM/PHG/24/5716",
"items": [
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKC"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKD"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKE"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKF"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKG"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKH"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKI"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKJ"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKK"
}
],
"id": "1",
"relatedLot": "1"
},
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKC"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKD"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKE"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKF"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKG"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKH"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKI"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKJ"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKK"
}
],
"id": "2",
"relatedLot": "2"
},
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKC"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKD"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKE"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKF"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKG"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKH"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKI"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKJ"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKK"
}
],
"id": "3",
"relatedLot": "3"
}
],
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"awardCriteria": {
"criteria": [
{
"description": "Price is not the only award criterion and all criteria are stated in the procurement documentation",
"name": "Price",
"type": "price"
}
],
"weightingDescription": "Price is not the only award criterion and all criteria are stated only in the procurement documents."
},
"contractPeriod": {
"endDate": "2028-05-31T23:59:59+01:00",
"maxExtentDate": "2030-05-31T23:59:59+01:00",
"startDate": "2026-06-01T00:00:00+01:00"
},
"description": "Lenalidomide\nCESW: (Midlands and Southwest): 1st June 2026 \u2013 31st May 2028\nNWLN: (Northwest and London North): 1st June 2026 \u2013 31st May 2028\nLSNE: (London South and Northeast): 1st June 2026 \u2013 31st May 2028",
"hasOptions": true,
"hasRenewal": true,
"id": "1",
"options": {
"description": "option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months."
},
"renewal": {
"description": "option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months."
},
"status": "active",
"suitability": {
"sme": true
},
"title": "Lenalidomide",
"value": {
"amount": 1.0,
"amountGross": 1.0,
"currency": "GBP"
}
},
{
"awardCriteria": {
"criteria": [
{
"description": "Price is not the only award criterion and all criteria are stated in the procurement documentation",
"name": "Price",
"type": "price"
}
],
"weightingDescription": "Price is not the only award criterion and all criteria are stated in the procurement documentation"
},
"contractPeriod": {
"endDate": "2028-05-31T23:59:59+01:00",
"maxExtentDate": "2030-05-31T23:59:59+01:00",
"startDate": "2026-06-01T00:00:00+01:00"
},
"description": "Pomalidomide\nCESW: (Midlands and Southwest): 1st June 2026 \u2013 31st May 2028\nNWLN: (Northwest and London North): 1st June 2026 \u2013 31st May 2028\nLSNE: (London South and Northeast): 1st June 2026 \u2013 31st May 2028",
"hasOptions": true,
"hasRenewal": true,
"id": "2",
"options": {
"description": "option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months."
},
"renewal": {
"description": "option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months."
},
"status": "active",
"suitability": {
"sme": true
},
"title": "Pomalidomide",
"value": {
"amount": 1.0,
"amountGross": 1.0,
"currency": "GBP"
}
},
{
"awardCriteria": {
"criteria": [
{
"description": "Price is not the only award criterion and all criteria are stated in the procurement documentation",
"name": "Price",
"type": "price"
}
],
"weightingDescription": "Price is not the only award criterion and all criteria are stated in the procurement documentation"
},
"contractPeriod": {
"endDate": "2028-05-31T23:59:59+01:00",
"maxExtentDate": "2030-05-31T23:59:59+01:00",
"startDate": "2026-06-01T00:00:00+01:00"
},
"description": "Thalidomide\nCESW: (Midlands and Southwest): 1st June 2026 \u2013 31st May 2028\nNWLN: (Northwest and London North): 1st June 2026 \u2013 31st May 2028\nLSNE: (London South and Northeast): 1st June 2026 \u2013 31st May 2028",
"hasOptions": true,
"hasRenewal": true,
"id": "3",
"options": {
"description": "option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months."
},
"renewal": {
"description": "option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months."
},
"status": "active",
"suitability": {
"sme": true
},
"title": "Thalidomide",
"value": {
"amount": 1.0,
"amountGross": 1.0,
"currency": "GBP"
}
}
],
"mainProcurementCategory": "goods",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"status": "active",
"submissionMethodDetails": "The procurement documents are\navailable for unrestricted and full direct\naccess, free of charge at https://health-family.force.com/s/Welcome\nAdditional information may be obtained\nfrom the abovementioned address.\nTenders must be submitted to the\nabove mentioned address.",
"submissionTerms": {
"electronicSubmissionPolicy": "allowed",
"languages": [
"en"
]
},
"techniques": {
"frameworkAgreement": {
"buyerCategories": "Please refer to Document No. 09 in the\nITO Documents for the list of\nPurchasing Points.",
"description": "Please refer to the ITO Documents for the Operation Description",
"method": "withReopeningCompetition",
"type": "open"
},
"hasFrameworkAgreement": true
},
"tenderPeriod": {
"endDate": "2026-03-09T13:00:00Z"
},
"title": "NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide \u0026 Thalidomide",
"value": {
"amount": 33981928.0,
"amountGross": 40778314.0,
"currency": "GBP"
}
}
}